Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.

Donor-specific (d-sp) interferon gamma enzyme-linked immunosorbent spot (d-sp ELISPOT) and Panel of reactive T-cell (PRT) ELISPOT assays have been developed to detect alloreactive memory T (Tmem) cells in order to estimate the risk of acute rejection after kidney transplantation. Adding IL15 to the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilaria Gandolfini, Elena Crespo, Mukta Baweja, Marta Jarque, Chiara Donadei, Sergio Luque, Núria Montero, Anna Allesina, Laura Perin, Umberto Maggiore, Paolo Cravedi, Oriol Bestard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200696&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850229283281174528
author Ilaria Gandolfini
Elena Crespo
Mukta Baweja
Marta Jarque
Chiara Donadei
Sergio Luque
Núria Montero
Anna Allesina
Laura Perin
Umberto Maggiore
Paolo Cravedi
Oriol Bestard
author_facet Ilaria Gandolfini
Elena Crespo
Mukta Baweja
Marta Jarque
Chiara Donadei
Sergio Luque
Núria Montero
Anna Allesina
Laura Perin
Umberto Maggiore
Paolo Cravedi
Oriol Bestard
author_sort Ilaria Gandolfini
collection DOAJ
description Donor-specific (d-sp) interferon gamma enzyme-linked immunosorbent spot (d-sp ELISPOT) and Panel of reactive T-cell (PRT) ELISPOT assays have been developed to detect alloreactive memory T (Tmem) cells in order to estimate the risk of acute rejection after kidney transplantation. Adding IL15 to the PRT assay (PRT+IL15) may uncover the presence of pathogenic alloreactive CD28-Tmem. Face-to-face comparisons of these assays have not been done yet. We performed pre-transplant d-sp ELISPOT and PRT assays (±IL15, against six B-cell lines) in 168 consecutive kidney transplant recipients and evaluated the multivariable-adjusted associations with biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and eGFR decline over a 48-month follow-up period. D-sp ELISPOT was positive in 81 (48%) subjects, while 71 (42%) and 81 (48%) subjects displayed positive PRT and PRT+IL15, respectively. Their median [interquartile range] numerical test result was 23 [6-65], 18 [8-37], and 26 [10-45] spots/3x105 PBMCs, respectively. The number of PRT spots were weakly correlated with those of d-sp ELISPOT, but highly correlated with PRT+IL15 (rho = 0.96, P<0.001). d-sp ELISPOT, but not PRT (±IL15) was independently associated with BPAR (adjusted Odds Ratio of BPAR associated with d-sp ELISPOT positivity: 4.20 [95%CI: 1.06 to 21.73; P = 0.041]). Unlike d-sp ELISPOT, median PRT and PRT+IL15 were independently associated with higher Δ3-48month eGFR decline post-transplantation (for both assays, about -3mL/min/1.73m2 per one standard deviation unit increase in the spot number). Pre-transplant T-cell immune-monitoring using d-sp ELISPOT and PRT assays identifies kidney transplant candidates at high risk of BPAR and worse kidney allograft progression.
format Article
id doaj-art-efd2f655be7c49e8ac4e45228bb2f3e6
institution OA Journals
issn 1932-6203
language English
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-efd2f655be7c49e8ac4e45228bb2f3e62025-08-20T02:04:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01137e020069610.1371/journal.pone.0200696Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.Ilaria GandolfiniElena CrespoMukta BawejaMarta JarqueChiara DonadeiSergio LuqueNúria MonteroAnna AllesinaLaura PerinUmberto MaggiorePaolo CravediOriol BestardDonor-specific (d-sp) interferon gamma enzyme-linked immunosorbent spot (d-sp ELISPOT) and Panel of reactive T-cell (PRT) ELISPOT assays have been developed to detect alloreactive memory T (Tmem) cells in order to estimate the risk of acute rejection after kidney transplantation. Adding IL15 to the PRT assay (PRT+IL15) may uncover the presence of pathogenic alloreactive CD28-Tmem. Face-to-face comparisons of these assays have not been done yet. We performed pre-transplant d-sp ELISPOT and PRT assays (±IL15, against six B-cell lines) in 168 consecutive kidney transplant recipients and evaluated the multivariable-adjusted associations with biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and eGFR decline over a 48-month follow-up period. D-sp ELISPOT was positive in 81 (48%) subjects, while 71 (42%) and 81 (48%) subjects displayed positive PRT and PRT+IL15, respectively. Their median [interquartile range] numerical test result was 23 [6-65], 18 [8-37], and 26 [10-45] spots/3x105 PBMCs, respectively. The number of PRT spots were weakly correlated with those of d-sp ELISPOT, but highly correlated with PRT+IL15 (rho = 0.96, P<0.001). d-sp ELISPOT, but not PRT (±IL15) was independently associated with BPAR (adjusted Odds Ratio of BPAR associated with d-sp ELISPOT positivity: 4.20 [95%CI: 1.06 to 21.73; P = 0.041]). Unlike d-sp ELISPOT, median PRT and PRT+IL15 were independently associated with higher Δ3-48month eGFR decline post-transplantation (for both assays, about -3mL/min/1.73m2 per one standard deviation unit increase in the spot number). Pre-transplant T-cell immune-monitoring using d-sp ELISPOT and PRT assays identifies kidney transplant candidates at high risk of BPAR and worse kidney allograft progression.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200696&type=printable
spellingShingle Ilaria Gandolfini
Elena Crespo
Mukta Baweja
Marta Jarque
Chiara Donadei
Sergio Luque
Núria Montero
Anna Allesina
Laura Perin
Umberto Maggiore
Paolo Cravedi
Oriol Bestard
Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
PLoS ONE
title Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
title_full Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
title_fullStr Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
title_full_unstemmed Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
title_short Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
title_sort impact of preformed t cell alloreactivity by means of donor specific and panel of reactive t cells prt elispot in kidney transplantation
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200696&type=printable
work_keys_str_mv AT ilariagandolfini impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT elenacrespo impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT muktabaweja impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT martajarque impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT chiaradonadei impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT sergioluque impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT nuriamontero impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT annaallesina impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT lauraperin impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT umbertomaggiore impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT paolocravedi impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation
AT oriolbestard impactofpreformedtcellalloreactivitybymeansofdonorspecificandpanelofreactivetcellsprtelispotinkidneytransplantation